According to a new report published by Introspective Market Research, titled, Neurology Devices Market by Device Type, Application, and End-User, The Global Neurology Devices Market Size Was Valued at USD 13 Billion in 2023 and is Projected to Reach USD 30.77 Billion by 2032, Growing at a CAGR of 8.8%. The neurology devices market delivers innovative technologies used in diagnosing, monitoring, and treating neurological disorders, including epilepsy, Parkinson’s, Alzheimer’s, stroke, and neuropathic pain. These devices encompass neurostimulation implants, interventional neurology tools, cerebrospinal fluid management systems, and sophisticated neurosurgical instruments, offering considerable advantages over traditional therapies by enabling earlier disease intervention, minimally invasive procedures, and improved long-term patient outcomes.
With the rising prevalence of neurological conditions worldwide and the aging population, the need for advanced neurology devices is escalating across hospitals, specialty clinics, and home care settings. The versatility and technological sophistication of these devices ensure their vital role in both acute and chronic neurological care, contributing to enhanced quality of life and reduced healthcare costs.
The Neurology Devices Market is segmented into Device Type, Application, and End-User.
- By Device Type: Neurostimulation Devices, Neurosurgery Devices, Interventional Neurology Devices, Cerebrospinal Fluid (CSF) Management Devices.
- By Application: Chronic Pain, Epilepsy, Parkinson’s Disease, Alzheimer’s Disease, Stroke, Multiple Sclerosis, and Others.
- By End-User: Hospitals & Clinics, Specialty Centers, and Others.
A major growth driver for the neurology devices market is the increasing prevalence of neurovascular and neurodegenerative disorders globally. Advancements in minimally invasive and image-guided device technology are bolstering demand, allowing healthcare providers to diagnose and treat neurological diseases with improved accuracy and safety. Growing investment in healthcare infrastructure and reimbursement schemes further supports market expansion, particularly in high-prevalence regions such as North America and Europe.
One key opportunity for the neurology devices market is the incorporation of artificial intelligence (AI) and wearable technologies in neuro_monitoring and neurostimulation platforms. These innovations enable earlier detection, real-time data analysis, and tailored therapy for patients, increasing long-term efficacy and enabling more convenient, patient-centered care. Integration of AI-powered closed-loop systems and remote monitoring opens new avenues for device manufacturers and healthcare providers to offer superior value with scalable, next-generation solutions.
Neurology Devices Market, Segmentation
The Neurology Devices Market is segmented on the basis of Device Type, Application, and End-User.
Device Type
The Device Type segment is further classified into Neurostimulation Devices, Neurosurgery Devices, Interventional Neurology Devices, Cerebrospinal Fluid Management Devices. Among these, the Neurostimulation Devices sub-segment accounted for the highest market share in 2023. Neurostimulation devices are widely used for chronic pain, epilepsy, Parkinson’s disease, and depression. Their popularity is driven by proven efficacy, widespread adoption for symptom management, and continued technological innovation, making them the cornerstone of minimally invasive neurological care.
Application
The Application segment is further classified into Chronic Pain, Epilepsy, Parkinson’s Disease, Alzheimer’s Disease, Stroke, Multiple Sclerosis, and Others. Among these, the Chronic Pain sub-segment accounted for the highest market share in 2023. Chronic pain affects millions globally and represents a significant healthcare burden, with neurostimulation devices providing validated relief where pharmaceutical approaches may fall short. The growing incidence of chronic pain and the pursuit of non-opioid solutions make this the leading application for neurology devices worldwide.
Some of The Leading/Active Market Players Are-
- Boston Scientific (USA)
- Medtronic (Ireland/USA)
- Abbott Laboratories (USA)
- Stryker Corporation (USA)
- Johnson & Johnson (USA)
- B.Braun SE (Germany)
- Penumbra Inc. (USA)
- LivaNova PLC (UK)
- Integra LifeSciences Holdings Corp. (USA)
- Zimmer Biomet (USA)
- Natus Medical Incorporated (USA)
- Magstim (UK)
- MicroPort Scientific Corporation (China)
- Nihon Kohden Corp. (Japan)
- Philips Healthcare (Netherlands)
- Other active players.
Key Industry Developments
In February 2025, Penumbra introduced the Access25 delivery microcatheter, engineered for precise navigation of the neurovasculature, supporting advanced embolization coil delivery and improved patient outcomes in interventional neurology. This launch reinforces Penumbra’s commitment to innovation in minimally invasive neurological procedures and expands its neurointerventional product portfolio.
In February 2024, Royal Philips unveiled significant upgrades to its Image Guided Therapy System, enhancing clinical productivity, faster decision-making, and better treatment outcomes in neuro interventions. These upgrades integrate AI-assisted planning and imaging, allowing personalized therapies to address complex neurological conditions more effectively.
Key Findings of the Study
- Neurostimulation devices and chronic pain application segments dominate global revenue.
- North America remains the leading region, with robust healthcare investment and major manufacturers.
- Key growth drivers include rising neurological disorder prevalence, technology innovation, and minimally invasive solutions.
- Industry trends favor AI-powered and wearable devices, multi-functional platforms, and remote neuro-monitoring adoption.
